Advisor Group Holdings, Inc. I Mab Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$12.54 - $46.93 $22,672 - $84,849	-1,808 Reduced 99.83%	3 $0
Q3 2021 Nov 05, 2021	BUY	$57.18 - $84.43 $102,009 - $150,623	1,784 Added 6607.41%	1,811 $131,000
Q2 2021 Aug 02, 2021	BUY	$47.86 - $83.95 $143 - $251	3 Added 12.5%	27 $2,000
Q3 2020 Nov 12, 2020	BUY	$27.46 - $47.03 $659 - $1,128	24 New	24 $1,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $77.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.